Transmyocardial laser revascularization (TMLR) is a new surgical techn
ique clinically tested in patients with advanced seven coronary arteri
osclerosis when classic routine treatment by medicaments, percutaneous
transluminal coronary angioplasty (PTCA), or aorto-coronary bypass su
rgery does not improve symptoms of ischemic heart disease. During the
procedure high-energy CO2 laser performs 35-40 transmyocardial channel
s via left-sided thoracotomy. Channels are drilled from the epicardial
side of the heart through the myocardium into the left ventricle cavi
ty. Impulses are synchronized with EKG (diastole), the channel diamete
r is about 1 mm. Transmural laser penetration is confirmed by intraope
rative transesophageal echocardiography (TEE). This technique is based
on a theory that channels allow blood supply from left ventricle dire
ctly into the intramyocardial vessels (possibly capillaries) and so im
prove oxygenation of ischemic myocardium. Presented are gross and micr
oscopic findings in a 75-year-old woman who suffered from classic clas
s IV angina with shortness of breath. She had a history of an inferior
myocardial infarct, ventricular tachyarrhythmia, aorto-coronary bypas
s, and mitral valvuloplasty. Her ejection fraction by echocardiography
was 25%. Angiographically, she had multiple occlusions of native coro
nary arteries and diffuse distal stenosis in the graft of the left int
ernal mammary artery (LIMA) to the left anterior descending coronary a
rtery (LAD). Thirty six of forty laser pulses were confirmed by TEE as
transmural. The patient died suddenly of ventricular fibrillation 5 d
ays after TMLR surgery. The autopsy was performed 6 hours after death.
After cross-sectioning of the heart all the laser-bored channels were
found partially or completely filled by fibrin and cell infiltrate co
mposed mainly of polymorphonuclear leukocytes. Patent channels were fo
und within myocardial scars, channels performed through viable myocard
ium appeared to be partially collapsed and occluded. (C) 1998 by Elsev
ier Science Inc.